Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products, including its flagship C-GAAP test, designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events.
Nicholas Leaves‘Membership Status’ indicates whether this member is an active reviewer on the site, and how many reviews have been published.
|Status:||No. Reviews Published:|
To be seen as an authority on SelectScience, find your products to review today., MRC geneservice
Transgenomic Announces Global Availability of CRC RAScan Test for Metastatic Colorectal Cancer Patients
17 May 2013
25 Sep 2012
01 Aug 2012
06 Jun 2012
Transgenomic, Inc. Launches Best-in-Class Next-Generation Sequencing Test for Nuclear Mitochondrial Disorders
20 Jun 2011